Skip to content
healthcare.dev
Get a free key

Entyvio

NDC 64764-300, vedolizumab, injection, powder, lyophilized, for solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
64764-300
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125476
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64764-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VEDOLIZUMAB300 mg/5mL

Pharmacologic classes

Integrin Receptor Antagonist [EPC]; Integrin Receptor Antagonists [MoA]

Package NDCNDC-11Package
64764-300-20647640300201 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e94621c-1a95-4af9-98d1-52b9e6f1949c

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=64764-300

Use it

Look up 64764-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64764-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64764-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.